The Pittsburgh-based tissue image-analysis company develops and applies automated pathology software to enable researchers to quantitatively analyze tissue changes in drug discovery, disease assessment, toxicology, and tissue engineering research.
BioImagene, based in
BioImagene said it plans to "rapidly" integrate TissueInformatics' core technology into its platform and application suite.
TissueInformatics' management team will help plant BioImagene's presence on the East coast and will maintain its facilities in
Clinical Data acquired Icoria last year for around $12.5 million. In 2004 Icoria changed its name from Paradigm Genetics after its acquisition of TissueInformatics earlier that year enabled it to change the focus of its business from plant genomics to systems biology and healthcare.